- News
- Cerevel Therapeutics
Tag:
Cerevel Therapeutics
-
AbbVie Inc. announced Monday that it will acquire Gilgamesh Pharmaceuticals’ treatment for major depressive disorder in a deal valued at up to $1.2 billion.25 Aug 2025-17:57
-